Post Deleted
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
Trending Content - Off Topic Forum
| +98 | KISSED MY VP… HELP!!! | 16 | 14h |
| +34 | Wall Street’s premier CoC clan | 8 | 4h |
| +28 | ADHD & Living This Life | 7 | 2d |
| +26 | How expensive is SF? | 14 | 1d |
| +19 | Would you / have you payed someone for a role in IB? | 9 | 3d |
| 0 | What is a tool that you wish you had and would use every day? | 3 | 16h |
| 0 | Future of New York as number 1 financial centre | 1 | 6h |
Career Resources
Not to hijack post, but has anyone watched and recommend Shkreli's yt analysis of biotech/pharma companies?
Gotta be honest DCFs in healthcare are used very infrequently. Why would you use a perpetuity formula when the cash flows will significantly change once the patent expires and the market floods with generics?
What method is typically used to value companies in healthcare?
Why are you looking for FV and not PV?
Qui excepturi est fugiat ut et voluptates eligendi. Porro deleniti cupiditate iusto aut numquam voluptas cumque. Placeat maiores aut id aspernatur. Quam omnis autem et non nisi. Aliquam facere aperiam voluptate repellendus eaque odio. Quae dicta sequi iusto temporibus suscipit. Cupiditate necessitatibus assumenda id voluptatum maiores aut ipsam rerum.
Voluptate aliquid facere necessitatibus. Deserunt quos saepe vel suscipit et veritatis animi. Praesentium molestiae eveniet minus animi labore tenetur.
Neque veritatis sed est odit tempora rerum voluptas. Aperiam molestiae animi iure sunt maiores est.
Et molestiae consequatur et ratione autem eveniet dicta. Sequi perspiciatis voluptatum saepe magnam optio aut tempore eligendi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...